ANIK: 阿尼卡医疗

ANIK新闻

• 14:19 Merck's Remigromig Meets Main Goal in Diabetic Macular Edema Study
• 12:40 Is Anika Therapeutics (ANIK) Outperforming Other Medical Stocks This Year?
• 14:38 AMGN's Dazodalibep Meets Goal in Systemic Sjogren's Disease Study
• 15:57 NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication
• 14:48 PBYI's Alisertib Combo Phase II Study in Small Cell Lung Cancer Begins
• 12:46 B. Riley Securities Assumes Anika Therapeutics at Buy, Raises Price Target to $23
• 12:46 B. Riley Securities将Anika Therapeutics股票评级调升至“买入”，并将目标股价提高至23美元
• 14:56 RCKT Aligns With FDA on Completing Phase II Study in Danon Disease
• 15:22 Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study
• 15:42 Roche Gets FDA Priority Tag for Enspryng in Rare Autoimmune Disorder
• 18:47 Novartis' Del-desiran Fails Late-Stage DM1 Study, Shares Fall
• 14:05 FDA Accepts & Gives Priority Review to Intellia's BLA for HAE Drug
• 14:48 ABBV's Etentamig Meets Goals in Phase III Multiple Myeloma Study
• 15:23 TEVA's TEV '408 Meets Goal in Phase IIa Celiac Disease Study
• 14:30 QURE Submits Application for Gene Therapy for Huntington's Disease
• 18:29 Novartis' Remibrutinib Delivers Positive Results in Late-Stage MS Studies
• 15:11 GSK to Advance mRNA Influenza Vaccine Into Phase III Development
• 14:52 OCGN Advances Gene Therapy OCU410 In Phase III for Geographic Atrophy
• 16:05 Axsome Begins Phase III Study on AXS-05 for Smoking Cessation
• 16:02 JAZZ Rises on Updated OS Results From Gastric Cancer Study
• 15:36 Teva Seeks to Boost Neuroscience Portfolio With BioXcel Asset Bid
• 15:10 ORKA Stock Up More Than 60% in 3 Months: Here's What You Should Know
• 14:00 Best Momentum Stocks to Buy for August 26th
• 16:10 J&J's Imaavy Gets FDA Approval as the First Treatment for wAIHA